<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>49</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2011</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Hepatitis-C and Hepatitis-B Co-Infections in Patients with Human Immunodeficiency Virus in Tehran, Iran</title>
    <FirstPage>252</FirstPage>
    <LastPage>257</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>SeyedAhmad</FirstName>
        <LastName>SeyedAlinaghi</LastName>
        <affiliation locale="en_US">Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Jam</LastName>
        <affiliation locale="en_US">Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Mehrkhani</LastName>
        <affiliation locale="en_US">Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Fattahi</LastName>
        <affiliation locale="en_US">Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran. AND Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Duman</FirstName>
        <LastName>Sabzvari</LastName>
        <affiliation locale="en_US">Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Kourorian</LastName>
        <affiliation locale="en_US">Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran. AND Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hossain</FirstName>
        <LastName>Jabbari</LastName>
        <affiliation locale="en_US">Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Minoo</FirstName>
        <LastName>Mohraz</LastName>
        <affiliation locale="en_US">Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">We carried out a study to determine the seroprevalence of HBV and HCV infections in HIV&#xA0;positive patients at a main referral center for HIV/AIDS in Iran. Serum samples from 201 HIV positive&#xA0;patients referring to a referral center for HIV/AIDS were analyzed for the presence of some hepatitis B&#xA0;(HBsAg, anti-HBc, anti-HBs) and Hepatitis C (anti-HCV) markers, during 2004- 2005. HBsAg was positive&#xA0;in 27 patients (13.4%), anti-HBc was positive in 60 patients (29.8%) and anti-HBs in 23 patients (11.4%).&#xA0;Anti-HCV Ab was positive in 135 of 201 (67.2%). HBV and HCV coinfection was observed in 73 of 201&#xA0;(36.3%). The maximum prevalence of HBV-HIV and HCV-HIV coinfections were seen in intravenous drug&#xA0;users; 61.2% and 85.1%, respectively (P&lt;0.0001). The minimum prevalence of HBV-HIV and HCV-HIV&#xA0;were seen in HIV patients&#xB4;wife (HIV+&#xA0;patients who were infected by monogamous sexual contact with their&#xA0;HIV positive husband) both of them were 8% (P&lt;0.0001). This study showed that HBV-HIV and HCV-HIV&#xA0;coinfections are significant in patients with HIV/AIDS in Iran. A greater relevance was observed in the&#xA0;association between HCV and HIV. This study suggests that it is necessary to investigate risk factors and risk&#xA0;groups for these infections in Iran.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/3733</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/3733/3708</pdf_url>
  </Article>
</Articles>
